Human CD34⁺ cells are hematopoietic stem and progenitor cells (HSPCs) isolated from peripheral blood, cord blood, or bone marrow using immunomagnetic sorting. CD34 is a well-established surface marker of early hematopoietic cells capable of self-renewal and multilineage differentiation into myeloid and lymphoid lineages.
Human CD34+ Cells
$600.00Price
- 1 mln cells/vial
- Post-thaw viability - ≥ 80%
- Purity - ≥ 90% CD34⁺
-
Hematopoietic lineage differentiation (myeloid, erythroid, lymphoid)
-
Engraftment in xenotransplant models (e.g., NSG mice)
-
Gene editing (e.g., CRISPR/Cas9 delivery in HSPCs)
-
Expansion in bioreactors or feeder-free systems
-
Stem cell mobilization and homing studies
-
Hematologic disease modeling and drug screening
-